Imagion Biosystems Limited

IBX

AU000000IBX6

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 10:20:03 28/03/2024 am IST			5-day change	1st Jan Change
0.074 ^AUD	-9.76%		-.--%	-79.15%

29/02	Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/01	Imagion Biosystems CEO Resigns	MT

Imagion Biosystems Limited Approves Election of Isaac Bright as Director

November 13, 2023 at 06:14 am IST

Imagion Biosystems Limited announced that at its Extraordinary General Meeting held on 13 November 2023, the shareholders approved Election of Director - Dr. Isaac Bright.

Latest news about Imagion Biosystems Limited

Imagion Biosystems Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02	CI
Imagion Biosystems CEO Resigns	15/01	MT
Imagion Biosystems Limited Informs Chairman Bob Proulx to Resume Operating Responsibilities as Interim Executive Chair	15/01	CI
Imagion Biosystems Limited Announces Departure of Isaac Bright as CEO	15/01	CI
Imagion Biosystems Validates Safety, Feasibility of Breast Cancer Imaging Agent in Phase One Trial; Shares Rise 7%	07/12	MT
Argenica Therapeutics Appoints Nonexecutive Chair	30/11	MT
Imagion Biosystems Limited Approves Election of Isaac Bright as Director	13/11	CI
Imagion Biosystems Completes Phase 1 Imaging Agent Study	18/23/18	MT
Imagion Biosystems Limited Announces Update on Magsense Her2 Program	02/23/02	CI
Imagion Biosystems Secures AU$3.5 Million R&D Tax Rebate for Fiscal Year 2022	19/23/19	MT
Imagion Biosystems Limited Reports Earnings Results for the Half Year Ended June 30, 2023	30/23/30	CI
Imagion Biosystems Limited Appoints Robert Proulx as Non-Executive Chairman	17/23/17	CI
Imagion Biosystems Limited Announces Executive Changes	17/23/17	CI
Easing Inflation Boosts Australian Shares	28/23/28	MT
Imagion Biosystems, Siemens Healthineers Expand US Collaboration; Shares Jump 33%	28/23/28	MT
Imagion Biosystems Completes Enrollment for Imaging Agent Trial; Shares Surge 25%	21/23/21	MT
Imagion Biosystems Appoints CEO	19/23/19	MT
Imagion Biosystems Limited Announces CEO Changes	19/23/19	CI
Imagion Biosystems Limited Announces Resignation of Bob Proulx as CEO	28/23/28	CI
Imagion Biosystems Raises AU$412,903 Via Entitlement Offer; Shares Slip 6%	19/23/19	MT
Imagion Biosystems Sets Timeline for Application Filing of US Phase 2 Study of Breast Cancer Imaging Agent	27/23/27	MT
Imagion Biosystems Limited Provides an Update on Development Plans for Its MagSense HER2 imaging agent	27/23/27	CI
Imagion Biosystems Limited announced that it expects to receive AUD 15 million in funding from Mercer Street Capital Partners, LLC	07/23/07	CI
Imagion Biosystems Secures Second Grant Funding for Prostate Cancer Imaging Technology	01/23/01	MT
Imagion Biosystems Limited Receives 2nd CSIRO Grant for Prostate Cancer Project	01/23/01	CI

Chart Imagion Biosystems Limited

Duration

Period

More charts

Imagion Biosystems Limited is a medical imaging company engaged in developing medical imaging technologies for various cancer types. The Company uses bio-safe magnetic nanoparticles to detect cancer and other diseases. Its principal activity consists of nanotechnology, biotechnology, cancer diagnostics and medical imaging using magnetic resonance. The Company operates through Research and Development segment. It is advancing clinical development of its MagSense platform technology to revolutionize cancer diagnosis, introducing molecular imaging to Magnetic resonance imaging (MRI). The Companyâs lead program has demonstrated its technology embodied in MagSense HER2 Imaging Agent (MSH2IA) is safe and well-tolerated in patients diagnosed with HER2+ breast cancer. Its MagSense pipeline includes prostate cancer, ovarian cancer, pancreatic cancer, and brain cancer programs. Its PrecisionMRX products include Dextran-Coated, mPEG Coated, Oleic Acid Coated and Carboxylic Acid Functionalized.

Sector

Advanced Medical Equipment & Technology

Calendar

28/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
IMAGION BIOSYSTEMS LIMITED	-79.15%	1.59M
SARTORIUS AG	-17.02%	18.51B
QUIDELORTHO CORPORATION	-42.09%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+23.15%	1.95B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	+3.08%	1.72B
BIOTAGE AB	+28.27%	1.26B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-11.16%	1.02B
CONTEC MEDICAL SYSTEMS CO.,LTD	-17.21%	950M
REVENIO GROUP OYJ	+0.07%	777M
VAREX IMAGING CORPORATION	-23.17%	643M

Medical Diagnostic & Testing Equipment